PolicyEconomic Times
India may open doors to multinational pharma firms for first-in-human Phase I trials
Positive+43
GreyOak summary
India plans to allow multinational pharmaceutical companies to conduct first-in-human Phase I clinical trials in the country. This regulatory overhaul aims to align India's drug oversight with global practices and attract global drug innovation. Officials note that existing infrastructure could be extended to support these trials alongside safeguards.
What it affects
- HealthcarePositive +43
India may allow MNCs for Phase I trials.Rolling sentiment Positive +39
